Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
2
×
life sciences
national blog main
480 biomedical
amgen
arsenal medical
bob langer
boston
boston blog main
boston top stories
calcitonin gene-related peptide
chronic migraine
chronic rhinosinusitis
covid-19
deals
drug delivery
drugs
eli lilly
episodic migraine
genzyme
george whitesides
indiana
indiana blog main
indiana top stories
inflammation
investing
ipo
keros therapeutics
lyra therapeutics
medical device
migraine
mometasone furorate
north bridge venture partners
oric pharmaceuticals
perceptive advisors
polaris venture partners
renaissance capital
startups
What
late
2
×
new
2
×
announced
approval
approved
biotech
class
company
debut
decision
developed
developing
drug
eli
fda
headache
ipo
lilly
lyra
markets
marks
medicines
migraine
million
nose
noses
pain
persistently
prevent
public
raised
raises
runny
starts
tech
tests
therapeutics
thursday
treat
way
Language
unset
Current search:
late
×
fda
×
new
×
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
